Rapport Therapeutics Appoints John Maraganore to Board of Directors

BOSTON & SAN DIEGO--(BUSINESS WIRE)--Rapport Therapeutics, Inc., a clinical-stage biotechnology company leveraging... Read more »

Johnson & Johnson Completes Ambrx Acquisition

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) announced today it has successfully completed... Read more »

Interview with Steve Holtzclaw, CEO at U.S. Orthopaedic Partners

Steve Holtzclaw, MD, MBA, is the CEO of U.S. Orthopaedic Partners, a position he assumed on January 1, 2024... Read more »

Gain exposure through our multi-channel news platform.

2024’s Best & Worst States for Children’s Health Care – WalletHub Study

Maverix Medical Acquires Cirrus Bio

Healthiest Cities in America (2024 Rankings) – WalletHub Study

Gilead Sciences Acquires CymaBay, For Approximately $4.3 Billion

Ocugen: A Speculative Buy In Biotech Growing Clinical Trials To Billion-Dollar Revenues

2024’s Best & Worst States for Doctors – WalletHub Study

Pfizer: It’s Darkest Before The Dawn, Upgrading To ‘Strong Buy’

2024’s Most Overweight and Obese Cities in the U.S. – WalletHub Study

Rakuten Medical Closes $119M Series E

Vivani Medical Appoints Daniel Bradbury To Its Board

Woodbridge International Closes Sale of Rayotek Scientific to McDanel Advanced Material Technologies

Rapport Therapeutics Appoints Kathy Wilkinson as Chief People Officer

Bristol Myers Squibb Completes Acquisition of RayzeBio

iBio Announces Sale of Preclinical PD-1 Agonist Antibody Program to Otsuka

Latigo Biotherapeutics Raises $135M in Series A

Pfizer Stock: It’s Time To Buy The Dip